227 related articles for article (PubMed ID: 23177475)
1. CCAAT/enhancer-binding protein δ is a critical mediator of lipopolysaccharide-induced acute lung injury.
Yan C; Johnson PF; Tang H; Ye Y; Wu M; Gao H
Am J Pathol; 2013 Feb; 182(2):420-30. PubMed ID: 23177475
[TBL] [Abstract][Full Text] [Related]
2. Critical role for CCAAT/enhancer-binding protein β in immune complex-induced acute lung injury.
Yan C; Wu M; Cao J; Tang H; Zhu M; Johnson PF; Gao H
J Immunol; 2012 Aug; 189(3):1480-90. PubMed ID: 22732594
[TBL] [Abstract][Full Text] [Related]
3. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.
Yan C; Ward PA; Wang X; Gao H
FASEB J; 2013 Aug; 27(8):2967-76. PubMed ID: 23585399
[TBL] [Abstract][Full Text] [Related]
4. C/EBPγ is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through the downregulation of C/EBPβ-/C/EBPδ-dependent C/EBP transcription activation.
Yan C; Zhang L; Yang L; Zhang Q; Wang X
FASEB J; 2020 Oct; 34(10):13696-13710. PubMed ID: 32786052
[TBL] [Abstract][Full Text] [Related]
5. C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.
Yan C; Zhu M; Staiger J; Johnson PF; Gao H
J Biol Chem; 2012 Jan; 287(5):3217-30. PubMed ID: 22147692
[TBL] [Abstract][Full Text] [Related]
6. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.
Sato S; Kawasaki T; Hatano R; Koyanagi Y; Takahashi Y; Ohnuma K; Morimoto C; Dudek SM; Tatsumi K; Suzuki T
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L562-L573. PubMed ID: 38469626
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Takashima K; Matsushima M; Hashimoto K; Nose H; Sato M; Hashimoto N; Hasegawa Y; Kawabe T
Respir Res; 2014 Nov; 15(1):150. PubMed ID: 25413579
[TBL] [Abstract][Full Text] [Related]
8. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways.
Moon C; Han JR; Park HJ; Hah JS; Kang JL
Respir Res; 2009 Mar; 10(1):18. PubMed ID: 19272161
[TBL] [Abstract][Full Text] [Related]
9. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
[TBL] [Abstract][Full Text] [Related]
10. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.
Peritore AF; D'Amico R; Siracusa R; Cordaro M; Fusco R; Gugliandolo E; Genovese T; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073872
[TBL] [Abstract][Full Text] [Related]
11. γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages.
Wang Y; Jiang Q
J Nutr Biochem; 2013 Jun; 24(6):1146-52. PubMed ID: 23246159
[TBL] [Abstract][Full Text] [Related]
12. γδ T cells protect against LPS-induced lung injury.
Wehrmann F; Lavelle JC; Collins CB; Tinega AN; Thurman JM; Burnham EL; Simonian PL
J Leukoc Biol; 2016 Feb; 99(2):373-86. PubMed ID: 26428678
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages.
Liu YW; Chen CC; Tseng HP; Chang WC
Cell Signal; 2006 Sep; 18(9):1492-500. PubMed ID: 16413748
[TBL] [Abstract][Full Text] [Related]
14. miR-146b overexpression ameliorates lipopolysaccharide-induced acute lung injury in vivo and in vitro.
He R; Li Y; Zhou L; Su X; Li Y; Pan P; Hu C
J Cell Biochem; 2019 Mar; 120(3):2929-2939. PubMed ID: 30500983
[TBL] [Abstract][Full Text] [Related]
15. Bigelovii A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Blocking NF-κB and CCAAT/Enhancer-Binding Protein δ Pathways.
Yan C; Guan F; Shen Y; Tang H; Yuan D; Gao H; Feng X
Mediators Inflamm; 2016; 2016():9201604. PubMed ID: 27194827
[TBL] [Abstract][Full Text] [Related]
16. The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model.
Bae HB; Li M; Kim JP; Kim SJ; Jeong CW; Lee HG; Kim WM; Kim HS; Kwak SH
Inflammation; 2010 Apr; 33(2):82-91. PubMed ID: 19838780
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein δ: multifaceted regulator in respiratory disease.
Duitman JW; Hoogendijk AJ; van der Poll T; Spek CA
Am J Pathol; 2013 Apr; 182(4):1459. PubMed ID: 23499053
[TBL] [Abstract][Full Text] [Related]
18. Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice.
Yin H; Jin XB; Gong Q; Yang H; Hu LY; Gong FL; Zhu JY
Int Immunopharmacol; 2008 Dec; 8(13-14):1842-7. PubMed ID: 18824250
[TBL] [Abstract][Full Text] [Related]
19. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38.
Zhao Q; Shepherd EG; Manson ME; Nelin LD; Sorokin A; Liu Y
J Biol Chem; 2005 Mar; 280(9):8101-8. PubMed ID: 15590669
[TBL] [Abstract][Full Text] [Related]
20. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
